Abstract
The effects of the selective prostaglandin D 2 (DP) receptor agonists, 572C85 ((±)-5-(3-carboxypropylthio)-1-(2-cyclohexyl-2-hydroxyethyl-amino)hexahydrocyclopenta( d)imidazol-2(1 H)-one) and 192C86 ((±)-5-(3-carboxypropylthio)-1-(2-cyclohexyl-2-hydroxyethylidene-amino)-3-ethylhexahydrocyclopenta( d)imidazol-2(1 H)-one), were determined on intraocular pressure regulation in rabbits and cats. 572C85 (50 μg) in rabbits maximally lowered intraocular pressure by 4.3 mm Hg, and significantly for 4 h compared to control. In cats 572C85 had a similar effect. 192C86 (50 μg) reduced intraocular pressure by 2.8 mm Hg for 2 h in rabbits. Following exposure to the specific DP receptor antagonist, BW A868C ((±)-3-benzyl-5-(6-carboxyhexyl)-1-(2-cyclohexyl-2-hydroxyethylamino)-hydantoin; 50 μg), which had no effect on intraocular pressure by itself, 572C85 (50 μg) did not reduce intraocular pressure in rabbits and cats. The intraocular pressure lowering effect of the mixed DP and EP receptor agonist, BW245C (5-(6-carboxyhexyl)-1-(3-cyclohexyl-3-hydroxypropyl)-hydantoin; 50 μg), in cats was suppressed by only 64% by BW A868C (50 μg). These results clearly show that the DP receptors in rabbit and cat eyes are involved in intraocular pressure regulation. However, under baseline conditions DP receptor activity does not contribute to this regulation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
